MFS
NVS icon

Monetta Financial Services’s Novartis NVS Stock Holding History

Monetta Financial Services’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,160
Closed -$927K – 106
2014
Q4 		$927K Buy
+11,160
New +$925K 0.48% 50

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Monetta Financial Services's NVS Position: Q1 2015 in Review

Monetta Financial Services sold out of Novartis (NVS) in Q1 2015, closing a stake of 11,160 shares — an estimated $927K sold.

Monetta Financial Services first reported a position in NVS in Q4 2014 and held it in 1 quarter. The position peaked at $927K in Q4 2014. 939 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

  • Monetta Financial Services reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
  • Monetta Financial Services sold 11,160 Novartis shares in Q1 2015, an estimated $927K.
  • Monetta Financial Services first reported a position in Novartis in Q4 2014 and held it in 1 quarter.
  • Monetta Financial Services's Novartis position peaked at $927K in Q4 2014.
  • 939 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Monetta Financial Services's 13F filing for Q1 2015, filed 11 May 2015.